Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Assessing the Key Attributes of Low Utilization of Mammography Screening and Breast-self Exam among African-American Women.

Chowdhury R, David N, Bogale A, Nandy S, Habtemariam T, Tameru B.

J Cancer. 2016 Feb 12;7(5):532-7. doi: 10.7150/jca.12963. eCollection 2016.

2.

Evaluating a bilingual patient navigation program for uninsured women with abnormal screening tests for breast and cervical cancer: implications for future navigator research.

Simon MA, Tom LS, Nonzee NJ, Murphy KR, Endress R, Dong X, Feinglass J.

Am J Public Health. 2015 May;105(5):e87-94. doi: 10.2105/AJPH.2014.302341. Epub 2015 Feb 25.

3.

Implementation of the National Breast and Cervical Cancer Early Detection Program: the beginning.

Lee NC, Wong FL, Jamison PM, Jones SF, Galaska L, Brady KT, Wethers B, Stokes-Townsend GA.

Cancer. 2014 Aug 15;120 Suppl 16:2540-8. doi: 10.1002/cncr.28820.

4.

Diffuse reflectance spectroscopy of epithelial tissue with a smart fiber-optic probe.

Yu B, Shah A, Nagarajan VK, Ferris DG.

Biomed Opt Express. 2014 Feb 10;5(3):675-89. doi: 10.1364/BOE.5.000675. eCollection 2014 Mar 1.

5.

Factors influencing breast cancer screening in low-income African Americans in Tennessee.

Patel K, Kanu M, Liu J, Bond B, Brown E, Williams E, Theriot R, Bailey S, Sanderson M, Hargreaves M.

J Community Health. 2014 Oct;39(5):943-50. doi: 10.1007/s10900-014-9834-x.

6.

Rapid determination of oxygen saturation and vascularity for cancer detection.

Hu F, Vishwanath K, Lo J, Erkanli A, Mulvey C, Lee WT, Ramanujam N.

PLoS One. 2013 Dec 16;8(12):e82977. doi: 10.1371/journal.pone.0082977. eCollection 2013.

7.

Intervention to improve follow-up for abnormal Papanicolaou tests: a randomized clinical trial.

Breitkopf CR, Dawson L, Grady JJ, Breitkopf DM, Nelson-Becker C, Snyder RR.

Health Psychol. 2014 Apr;33(4):307-16. doi: 10.1037/a0032722. Epub 2013 Jun 3.

8.

Factors influencing time to diagnosis after abnormal mammography in diverse women.

Pérez-Stable EJ, Afable-Munsuz A, Kaplan CP, Pace L, Samayoa C, Somkin C, Nickleach D, Lee M, Márquez-Magaña L, Juarbe T, Pasick RJ.

J Womens Health (Larchmt). 2013 Feb;22(2):159-66. doi: 10.1089/jwh.2012.3646. Epub 2013 Jan 25.

9.

Mind the gap: racial differences in breast cancer incidence and biologic phenotype, but not stage, among low-income women participating in a government-funded screening program.

Cunningham JE, Walters CA, Hill EG, Ford ME, Barker-Elamin T, Bennett CL.

Breast Cancer Res Treat. 2013 Jan;137(2):589-98. doi: 10.1007/s10549-012-2305-0. Epub 2012 Dec 13.

10.

Variations in practice guideline adherence for abnormal cervical cytology in a county healthcare system.

Singhal R, Rubenstein LV, Wang M, Lee ML, Raza A, Holschneider CH.

J Gen Intern Med. 2008 May;23(5):575-80. doi: 10.1007/s11606-008-0528-x. Epub 2008 Feb 20.

11.

Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis.

Sassi F, Luft HS, Guadagnoli E.

Am J Public Health. 2006 Dec;96(12):2165-72. Epub 2006 Oct 31.

12.

Should all children be immunised against hepatitis A?

Temte JL.

BMJ. 2006 Mar 25;332(7543):715-8. Review. No abstract available.

13.

The frequency of Pap smear screening in the United States.

Sirovich BE, Welch HG.

J Gen Intern Med. 2004 Mar;19(3):243-50.

14.

Supplemental Content

Support Center